Moderna President Stephen Hoge Files Form 144 to Sell $8.37M in Common Stock

Executive Summary

On October 14, 2026, Stephen Hoge, Officer and President of Moderna, Inc. (NASDAQ: MRNA), submitted a Form 144 notice of proposed sale covering 39,224 shares of Common Stock with an estimated aggregate market value of $8,373,519.16 (approximately $213.48 per share).

Transaction Details

• Acquisition Nature: The shares are being acquired on October 14, 2026, through a stock option exercise from the issuer paid in cash.
• Trading Plan: The proposed disposition is executed pursuant to a pre-established Rule 10b5-1 trading plan adopted on June 15, 2026.
• Broker: Fidelity Brokerage Services LLC.

Past 3-Month Activity

Stephen Hoge has engaged in several programmed sales over the trailing three months:

• 07/15/2026: 53,336 shares sold for $3,605,513.60
• 09/14/2026: 40,294 shares sold for $5,807,747.48
• 09/15/2026: 40,281 shares sold for $5,883,708.71

Significance Assessment

The filing reflects planned insider liquidation of option-acquired equity under a Rule 10b5-1 plan rather than discretionary spot-market transactions. Due to the high aggregate transaction value ($8.37M) combined with consistent monthly dispositions, the trading significance is categorized as Medium.